References
- Cervero F, Laird JM. From acute to chronic pain: mechanisms and hypotheses. Prog Brain Res 1996; 110: 3–15
- Fields H. Pain. New York: McGraw-Hill, 1987: 124
- The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329(14): 977–86
- The Capsaicin Study Group. Treatment of painful diabetic neuropathy with topical capsaicin: a multicenter, double-blind, vehicle-controlled study. Arch Intern Med 1991; 151(11): 2225–9
- Rowbotham MC, Davies PS, Fields HL. Topical lidocaine gel relieves postherpetic neuralgia. Ann Neurol 1995; 37(2): 246–53
- Rowbotham M, Harden N, Stacey B, et al. Gabapentin for the treatment of postherpetic neuralgia: a randomized controlled trial. JAMA 1998; 280(21): 1837–42
- Backonja M, Beydoun A, Edwards KR, et al, for the Gabapentin Diabetic Neuropathy Study Group. Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial. JAMA 1998; 280(21): 1831–6
- Max MB, Lynch SA, Muir J, et al. Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy. N Engl J Med 1992; 326(19): 1250–6
- Max MB, Schafer SC, Culnane M. Amitriptyline, but not lorazepam, relieves postherpetic neuralgia. Neurology 1988; 38(9): 1427–32
- Oskarsson P, Ljunggren JG, Lins PE, for the Mexiletine Study Group. Efficacy and safety of mexiletine in the treatment of painful diabetic neuropathy. Diabetes Care 1997; 20(10): 1594–7
- Wright JM, Oki JC, Graves L 3d. Mexiletine in the symptomatic treatment of diabetic peripheral neuropathy. Ann Pharma- cother 1997; 31(1): 29–34
- Arner S, Meyerson BA. Lack of analgesic effect of opioids on neuropathic and idiopathic forms of pain. Pain 1988; 33(1): 11–23